Jeffrey Alan Wolf
CIK 1381450 · Chief Executive Officer · last filed 2026-01-06
Jeffrey Alan Wolf is a Chief Executive Officer who has filed 37 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for TOVX, was dated Jan 6, 2026. Current disclosed insider exposure totals $5.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.0K
7
37
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TOVX | Director | — | $0.30 | — | $0 | 4 | 2026-01-06 |
| SCPX | Chief Executive Officer | 3,583,814 | $0.00 | $5.0K | $0 | 1 | 2024-05-17 |
| Scorpius Holdings, Inc. (NHWK) Delisted | Chief Executive Officer | — | $0.41 | — | $0 | 1 | 2022-12-09 |
| Scorpius Holdings, Inc. (HTBX) Delisted | Chief Executive Officer | 1,083,020 | $2.38 | $2.58M | $0 | 16 | 2022-01-03 |
| Theriva Biologics, Inc. (SYN) Delisted | Director | 10,842 | $1.02 | $11.1K | $0 | 10 | 2021-12-27 |
| Theriva Biologics, Inc. (AEN) Delisted | Director | — | — | — | $0 | 3 | 2011-01-07 |
| Theriva Biologics, Inc. (PP) Delisted | Director | — | $26.10 | — | $0 | 1 | 2007-11-06 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | TOVX | Grant (A) | — | $0 | EDGAR |
| 2025-05-01 | TOVX | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | SCPX | Grant (A) | +2,500,000 | $0 | EDGAR |
| 2023-12-15 | TOVX | Grant (A) | — | $0 | EDGAR |
| 2022-12-16 | TOVX | Grant (A) | — | $0 | EDGAR |
| 2022-12-09 | Scorpius Holdings, Inc. (NHWK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-03 | Scorpius Holdings, Inc. (HTBX) Delisted | Mixed | — | $0 | EDGAR |
| 2021-12-27 | Theriva Biologics, Inc. (SYN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-15 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | +246,305 | $0 | EDGAR |
| 2021-01-06 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | +288,100 | $0 | EDGAR |